DiaTech Oncology Test Shows Positive Results, Identifies New Therapeutic Strategies for Patients With Lung Cancer and Ovarian Cancer

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NASHVILLE, Tenn.--(BUSINESS WIRE)--DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville, Tenn., has developed a predictive test that has been effective in clinical trials in helping oncologists determine the best chemotherapy treatment plans and therapeutic strategies for more than 50 types of cancers. The company has just published detailed results of the clinical trials for mesothelioma lung cancer, small-cell lung cancer (NSCLC) and advanced stage III and IV ovarian cancer at the American Society of Clinical Oncology (ASCO) conference held in Chicago.

Help employers find you! Check out all the jobs and post your resume.